Back

ECHNO-ICHNO 2023 - 10th European Congress on Head & Neck Oncology

Mar 08 - Mar 11, 2023 | LisbonPortugal

LARVOL is not affiliated with 10th European Congress on Head & Neck Oncology and all trademarks, logos, and brand names are property of their respective owners

Condition
Stage
Treatment
Setting
Biomarker
Trial Name/ID

Showing 9 abstracts linked to Trials

Predictive value of body composition assessment in R/M SCCHN treated with immunotherapy (NCT04721184)

Exercise prehabilitation in head & neck cancer patients: Preliminary results of the FIT4TREAT trial

Elective neck irradiation guided by sentinel node biopsy in larynx & pharynx cancer: the PRIMO trial

A randomized trial of reduced elective neck radiation dose in head & neck cancer: acute toxicity

InGReS: Intra-treatment Image-Guided Adaptive Radiotherapy Dose-escalation - a Phase 1 study

Diagnostic test accuracy of sentinel lymph node biopsy in larynx & pharynx cancers: a meta-analysis

  • Oral, Proffered Paper

Net treatment benefit of avasopasem manganese for severe oral mucositis from the ROMAN trial

  • Oral, Proffered Paper

Neoadjuvant Leukocyte Interleukin Injection (LI) extends locally advanced SCCHN overall survival

Durable response after neoadjuvant immunotherapy in resectable CSCC: The MATISSE trial NCT04620200